Neko Health is a technology company.
Neko Health has raised $325.0M across 2 funding rounds.
Neko Health has raised $325.0M in total across 2 funding rounds.
Neko Health has raised $325.0M in total across 2 funding rounds.
Neko Health's investors include Atomico, Dig Ventures, foobar.vc, Hummingbird Ventures, Insignia Ventures Partners, Lakestar, Lightspeed Venture Partners, Lionheart Ventures, MassMutual Ventures, Pear VC, Picus Capital, Aaron Harris.
Neko Health is a Swedish health-tech company that builds advanced full-body scanning technology using AI, sensors, and non-invasive methods to enable preventive healthcare and early disease detection.[1][2][3] It serves individuals concerned about skin, heart, and vascular health, solving the problem of reactive healthcare by providing quick, affordable scans that detect risks like skin cancer, high blood pressure, and metabolic syndrome before symptoms appear.[1][5][7] Priced at €250–€300 per scan, the service operates clinics in Stockholm and London, with expansion planned to other European countries and the US, tracking health trends via an app for ongoing monitoring.[1][2][5]
The company's growth momentum includes a public launch in February 2023 after four years of development, rapid popularity in Sweden, and international expansion, backed by co-founder Daniel Ek's resources from Spotify.[2][5]
Neko Health was co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek, Spotify's co-founder and CEO, initially operating as HJN Sverige.[2][3][5][6] Nilsonne, with a background in health-tech innovation, and Ek, leveraging his tech entrepreneurship, identified a gap in preventive care amid exploding health data from wearables like Fitbits and Apple Watches.[5] The idea emerged from a vision to shift healthcare from symptom treatment to proactive prevention using AI and sensors, leading to five years of prototyping hardware for clinics and AI software for data analysis.[2][5]
Pivotal moments include multiple clinical studies to validate efficacy and the 2023 public launch in Stockholm, where bookings opened for skin and heart scans followed by immediate doctor consultations.[2] Early traction built in Sweden, culminating in a 2024 London clinic opening.[1][5]
Neko Health stands out in preventive health scanning through these key features:
| Feature | Neko Health | Prenuvo/Ezra (MRI-based) |
|---|---|---|
| Core Tech | 3D scan, infrared, ultrasound, ECG, AI | Full-body MRI |
| Radiation | None | None |
| Scan Time | Minutes | Longer |
| Cost | €250–€300 | Higher |[1]
Neko Health rides the preventive healthcare trend, fueled by AI advancements, sensor proliferation from wearables, and a shift from reactive to proactive medicine amid rising chronic disease burdens.[2][4][5] Timing aligns with post-pandemic emphasis on early detection, reducing healthcare costs by catching issues like heart disease or cancer pre-symptomatically.[1][6]
Market forces favoring it include AI's ability to process vast data for "sensible conclusions," clinician shortages making routine checks scarce, and consumer demand for affordable, non-invasive options over hospital waits.[4][5] It influences the ecosystem by challenging traditional diagnostics, inspiring sensor-AI hybrids, and scaling via clinics/apps, potentially lowering system-wide burdens as it expands globally.[1][2]
Neko Health is poised to disrupt preventive care by scaling its clinic model across Europe and the US, integrating more biomarkers, and leveraging AI for predictive trends from longitudinal app data.[1][5] Trends like multimodal AI diagnostics and wearable integration will accelerate its growth, while regulatory validations from ongoing studies could boost adoption amid aging populations and cost pressures.[2]
Its influence may evolve from niche scanner to platform leader, empowering individuals and easing public health systems—echoing its founding vision of health for the "future self," much like Spotify transformed music access.[7]
Neko Health has raised $325.0M across 2 funding rounds. Most recently, it raised $260.0M Series B in January 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2025 | $260.0M Series B | Atomico, Dig Ventures, foobar.vc, Hummingbird Ventures, Insignia Ventures Partners, Lakestar, Lightspeed Venture Partners, Lionheart Ventures, MassMutual Ventures, Pear VC, Picus Capital, Aaron Harris, Alexandre Prot, Andreas Ehn, Khaled Helioui, Pierpaolo Barbieri, Steve Anavi | |
| Jul 1, 2023 | $65.0M Series A | Atomico, Dig Ventures, foobar.vc, Lakestar, Lightspeed Venture Partners, Khaled Helioui |